Project Grant R01CA288827
Award Date
2/1/25
Completion Date
1/31/30
Dollars Obligated
$698K
Federal Agency
National Cancer Institute
Federal Grant Program
93.396
Assistance Type
Project Grant
Place of Performance
Washington, USA
Similar Awards
This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $626,893 in funding to the University of Texas MD Anderson Cancer Center to investigate the role of bacterial-colonized microniches within tumors and their impact on intratumoral heterogeneity and cancer progression. The research aims to: 1) Map the spatial distribution and cellular interactions of these bacterial-colonized microniches within patient tumor tissues, 2) Identify the human...
This $1,384,482 five-year Project Grant award from the National Cancer Institute's Cancer Biology Research program (CFDA 93.396) supports research at the University of Texas MD Anderson Cancer Center to investigate the role of bacterial DNA methyltransferases in cancer pathogenesis. The study will evaluate how the DNA methylation enzyme (M.FNI) from the colorectal cancer-associated bacterium Fusobacterium nucleatum impacts bacterial adaptation and host epigenetic regulation. Researchers will...
This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) supports research investigating the role of the bacterial species Fusobacterium nucleatum (Fn) and the protein Annexin A1 in the development and progression of colorectal cancer. The award totaling $600,499 will fund research to: (I) examine the mechanisms by which the amyloid-like form of the Fn adhesin protein FadA stimulates colorectal cancer growth, and (II) investigate the function of Annexin...
This $660,742 Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports research at The University of Texas MD Anderson Cancer Center to understand how a specific bacteria, Lactobacillus iners, influences cervical cancer metabolism and treatment resistance. The project aims to develop novel therapeutic approaches to target the tumor microbiome, either by eliminating or replacing L. iners, or by modulating its metabolic effects. As part of this...
This federal Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $537,985 in funding to The University of Texas MD Anderson Cancer Center to conduct research on the role of microbes in pancreatic cancer development and metastasis. The key objectives of this 5-year research project are to: Characterize the location, distribution, and functional properties of microbes within the pancreatic tumor microenvironment, including primary tumors and...
The National Cancer Institute (NCI) awarded a Project Grant totaling $253,405 to The Trustees of Columbia University in the City of New York under the Cancer Research Manpower (CFDA 93.398) federal grant program. The project aims to improve bacterial cancer therapeutics by identifying and understanding the mechanisms by which Escherichia coli bacteria migrate to and grow within tumors. This research seeks to develop strategies to enhance the tumor-specific colonization and delivery of...
This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) to the University of Texas MD Anderson Cancer Center will support research to investigate the role of the GRAIL gene in controlling intestinal inflammation and its link to colorectal cancer development. The $163,500 award, running from July 1, 2024 to June 30, 2026, will fund studies to determine how GRAIL expression in T follicular helper (Tfh) cells impacts intestinal homeostasis and tumor...
This $678,399 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program will fund a prebiotic diet intervention study at The University of Texas MD Anderson Cancer Center. The study aims to evaluate the impact of a prebiotic-enriched diet on enhancing the gut microbiome and improving immunotherapy response in patients with metastatic melanoma. The research will assess the effects of this dietary intervention on the gut...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $606,839 to Weill Medical College of Cornell University to conduct research on the role of gut microbiota amino acid metabolism in cancer. The key objectives are to: 1) Identify microbes and their metabolic genes that deplete intestinal amino acids and evaluate how this affects the tumor microenvironment and cancer progression; 2) Elucidate the molecular mechanisms by which...
The federal Project Grant award, valued at $1,690,396.00 and issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports epigenetic research on BRAF-mutant colorectal cancers at The University of Texas MD Anderson Cancer Center. The research aims to investigate the epigenetic mechanisms and targeting approaches during the response to BRAF inhibitor and anti-EGFR therapy for BRAF-mutant colorectal cancers. The award period runs from...